- Based on the "Company Law of the People's Republic of China" and the relevant provisions of the Shenzhen Stock Exchange, Shanghai Lanwei Medical Testing Co., Ltd. (hereinafter referred to as "the Company") announces the implementation of the 2025 annual equity distribution plan as follows: As of December 31, 2025, the total share capital of the Company is 400,517,000 shares, excluding the 1,996,100 shares held by the Company’s repurchase account, the remaining shares are 398,520,900 shares. The cash dividend is 1.80 RMB per share (tax included), totaling 71,733,762.00 RMB (tax included), and no redemptions or capital reserves will be distributed.
301060SZSE
Announcement on the Implementation of the 2025 Annual Equity Distribution
✨ AI Summary
This announcement details the implementation of the 2025 annual equity distribution plan for Shanghai Lanwei Medical Testing Co., Ltd. The total share capital is 400,517,000 shares, with a distribution of 1.80 RMB per share. The record date for the distribution is June 5, 2026, and the payment date is June 8, 2026.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.